Randomized controlled trial2016

Harnessing the Power of Cruciferous Vegetables: Developing a Biomarker for Brassica Vegetable Consumption Using Urinary 3,3'-Diindolylmethane

Fujioka N, Ransom BW, Carmella SG, Upadhyaya P, Lindgren BR, Roper-Batker A, Hatsukami DK, Fritz VA, Rohwer C, Hecht SS

Cancer prevention research (Philadelphia, Pa.) · 22 citations

Review labels

Controlled feeding

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
No health outcome
Intake measured by
Food provided by researchers

Who paid for it

Funding
Independent funding
Government
National Institutes of Health
Government
National Heart, Lung, and Blood Institute
Government
National Cancer Institute
Government
National Center for Advancing Translational Sciences
Government
NCI NIH HHS
Government
NHLBI NIH HHS
Government
NIH
Government
NHLBI
Government
NCATS NIH HHS
Grants
National Cancer Institute (P30 CA-077598); National Heart, Lung, and Blood Institute (T32 HL007062); National Heart, Lung, and Blood Institute (5T32HL007062-34); National Center for Advancing Translational Sciences (UL1 TR-000114); National Institutes of Health (P30 CA 77598)

Based on 9 listed funder(s).

Publication

Published
2016-08-18 · Cancer Prev Res (Phila) · vol. 9 · issue 10 · pp. 788–793
Publisher
American Association for Cancer Research
Cited
29 citations · more than 88% of similar papers · 2.3× the field average
References
33 works
Access
Open access (repository copy)
Research areas
Genomics, phytochemicals, and oxidative stress · Bioactive Compounds and Antitumor Agents · Glutathione Transferases and Polymorphisms
Keywords
Brassica, Cruciferous vegetables, Urinary system, Urine, Metabolite, Chemistry, Food science, Biomarker, Medicine, Cancer, Biology, Internal medicine, Botany, Biochemistry
MeSH
humans, brassica, indoles, glucosinolates, chromatography, liquid, diet, adult, middle aged, tandem mass spectrometry, young adult, biomarkers

10 authors

From US

  • Naomi Fujioka · correspondingUniversity of Minnesota
  • Benjamin W.S. RansomUniversity of Minnesota
  • Steven G. CarmellaUniversity of Minnesota
  • Pramod UpadhyayaUniversity of Minnesota
  • Bruce R. LindgrenUniversity of Minnesota
  • Astia Roper-BatkerUniversity of Vermont

Abstract

Glucobrassicin in Brassica vegetables gives rise to indole-3-carbinol (I3C), a compound with potent anticancer effects in preclinical models. We previously showed that the urinary metabolite 3,3'-diindolylmethane (DIM) could discriminate between volunteers fed high and low doses of Brassica vegetables. However, the quantitative relationship between glucobrassicin exposure and urinary DIM level is unclear. We conducted a clinical trial to examine the hypotheses that a range of glucobrassicin exposure from Brassica vegetables is reflected in urinary DIM and that this effect plateaus. Forty-five subjects consumed vegetables, a mixture of brussels sprouts and/or cabbage, at one of seven discrete dose levels of glucobrassicin ranging from 25 to 500 μmol, once daily for 2 consecutive days. All urine was collected for 24 hours after each vegetable-eating session. Urinary DIM was measured using our published liquid chromatography-electrospray ionization-tandem mass spectrometry-selected reaction monitoring (LC/ESI-MS/MS-SRM) method. Urinary DIM excretion increased predictably with increasing glucobrassicin dose and plateaued between 200 and 300 μmol of glucobrassicin. The association between glucobrassicin dose and urinary DIM was strong and positive (R2 = 0.68). The majority of DIM was excreted in the first 12 hours after vegetable consumption. We conclude that urinary DIM is a reliable biomarker of glucobrassicin exposure and I3C uptake and that feeding glucobrassicin beyond 200 μmol did not consistently lead to more urinary DIM, suggesting a plateau in potential chemopreventive benefit. Cancer Prev Res; 9(10); 788-93. ©2016 AACR.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.